Similarly, our results are consistent with those reported by Cavallaro et al., who investigated the relationship between PTL and KRAS status in a mixed National Cancer Data Base (NCDB) cohort of resectable and unresectable patients with CRC and synchronous metastases to the liver [26]. The gene discussed is KRAS; the disease is colorectal carcinoma.